Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates: https://www.valuewalk.com/wp-content/uploads/2023/08/Rental-Rate-1.jpg
Residential Prices, Rents Dip Across Qatar As World Cup Boost Dissipates

Residential market declines amid supply surge, office market faces oversupply challenges, retail market competes with increasing pressure, and hotel occupancy falters despite spike in tourist

Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines

therascreen® PDGFRA RGQ PCR-Kit von QIAGEN in USA zugelassen, um Patienten mit inoperablen oder metastasierenden gastrointestinalen Stromatumoren und PDGFRA-D842V-Mutation zu ermitteln, die für eine

Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
Therapie von gastrointestinalen Stromatumoren: QIAGEN erhält FDA-Zulassung für Begleitdiagnostikum zu AYVAKIT® (avapritinib) von Blueprint Medicines

therascreen® PDGFRA RGQ PCR-Kit von QIAGEN in USA zugelassen, um Patienten mit inoperablen oder metastasierenden gastrointestinalen Stromatumoren und PDGFRA-D842V-Mutation zu ermitteln, die für eine

BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklunghttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
  • Wichtige Fortschritte in der Weiterentwicklung der Pipeline durch den Beginn der zulassungsrelevanten Phase-3-Studie mit BNT316/ONC-392 sowie Vorbereitungen für mehrere geplante Studienstarts im
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklunghttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2023 und Informationen zur Geschäftsentwicklung
  • Wichtige Fortschritte in der Weiterentwicklung der Pipeline durch den Beginn der zulassungsrelevanten Phase-3-Studie mit BNT316/ONC-392 sowie Vorbereitungen für mehrere geplante Studienstarts im
Gov. Abbott Announces $87.7M in Housing Tax Credits from Texas: https://www.valuewalk.com/wp-content/uploads/2023/01/New-Homes-300x150.jpeg
Gov. Abbott Announces $87.7M in Housing Tax Credits from Texas

Texas Governor Greg Abbott announced on Monday that the Texas Department of Housing and Community Affairs (TDHCA) had awarded almost $90 million in tax credits. These housing tax credits from Texas

QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche

Neue Partnerschaft mit Niba Labs ermöglicht Biopharma-Kunden Zugang zu Dienstleistungen für maßgeschneidertes digitales PCR-Testdesign // Neues CGT Viral Vector Lysis Kit bietet standardisierten

QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QIAGEN erweitert Angebot an digitalen PCR-Kits und -Dienstleistungen für Biopharma-Branche

Neue Partnerschaft mit Niba Labs ermöglicht Biopharma-Kunden Zugang zu Dienstleistungen für maßgeschneidertes digitales PCR-Testdesign // Neues CGT Viral Vector Lysis Kit bietet standardisierten

15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022: https://www.valuewalk.com/wp-content/uploads/2023/07/Biopharma-Companies.jpg
15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022

The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma

15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022: https://www.valuewalk.com/wp-content/uploads/2023/07/Biopharma-Companies.jpg
15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022

The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma

House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You: https://www.valuewalk.com/wp-content/uploads/2019/10/property_1571794223-300x205.jpg
House, Senate Pass $18B Texas Property Tax Relief Bill: How it Benefits You

Ending the month-long stalemate, the Texas House on Thursday approved the landmark property tax relief bill that was passed by the Senate a day before. The $18 billion Texas property tax relief

Pfizer Just Invested $25 Million In This Biotech: https://www.valuewalk.com/wp-content/uploads/2023/07/Caribou-Biosciences-1.jpg
Pfizer Just Invested $25 Million In This Biotech

Key Points

  • Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
  • The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
Pfizer Just Invested $25 Million In This Biotech: https://www.valuewalk.com/wp-content/uploads/2023/07/Caribou-Biosciences-1.jpg
Pfizer Just Invested $25 Million In This Biotech

Key Points

  • Caribou surged 45% yesterday after news broke that Pfizer invested $25 million.
  • The investment by Pfizer signals a strong confidence in Caribou’s pipeline and lead candidates.
New Property Tax Relief From New Jersey Signed Into Law: https://www.valuewalk.com/wp-content/uploads/2023/06/New-Jersey-300x150.jpeg
New Property Tax Relief From New Jersey Signed Into Law

New Jersey lawmakers last week approved a new property tax relief program for seniors to help them offset the state’s sky-high property taxes. Under the program, eligible seniors will get up to

OKX Named Official Sleeve Partner Of Manchester City In Expansion Of Partnership: https://www.valuewalk.com/wp-content/uploads/2023/06/MANCITY_X_OKX_HERO_ENDFRAME_16x9_16881336124JGrE7RzuK-300x180.jpg
OKX Named Official Sleeve Partner Of Manchester City In Expansion Of Partnership

Manchester, UK, June 30th, 2023, Chainwire

Manchester City and OKX, one of the leading crypto exchanges by trading volume and a leading Web3 technology company, today announced OKX as the Club’s

The Top Most-Shorted Stocks Globally: https://www.valuewalk.com/wp-content/uploads/2023/06/LOVE_2023-06-19_20-01-41.jpg
The Top Most-Shorted Stocks Globally

Short-selling is one of the hottest investing-related topics of all time and a popular trading strategy. Investors usually invest in stocks they expect to get more valuable over time. On the other

QuantiFERON-TB Gold Plus von QIAGEN mit CD8-Technologie zeigt einzigartigen klinischen Nutzen in neuer Metaanalyse von Tuberkulose-Screenings: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QuantiFERON-TB Gold Plus von QIAGEN mit CD8-Technologie zeigt einzigartigen klinischen Nutzen in neuer Metaanalyse von Tuberkulose-Screenings

Erste systematische Auswertung zur klinischen Relevanz von Testwerten aus QuantiFERON-TB Gold Plus TB1- und TB2-Blutentnahmeröhrchen veröffentlicht // Studie mit 4.050 Versuchspersonen unterstreicht

QuantiFERON-TB Gold Plus von QIAGEN mit CD8-Technologie zeigt einzigartigen klinischen Nutzen in neuer Metaanalyse von Tuberkulose-Screenings: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24065/Qiagen_Logo.svg.png
QuantiFERON-TB Gold Plus von QIAGEN mit CD8-Technologie zeigt einzigartigen klinischen Nutzen in neuer Metaanalyse von Tuberkulose-Screenings

Erste systematische Auswertung zur klinischen Relevanz von Testwerten aus QuantiFERON-TB Gold Plus TB1- und TB2-Blutentnahmeröhrchen veröffentlicht // Studie mit 4.050 Versuchspersonen unterstreicht

Displate bringt offizielle League of Legends-Kollektion in Zusammenarbeit mit dem LEC heraus
Displate bringt offizielle League of Legends-Kollektion in Zusammenarbeit mit dem LEC heraus

In Zusammenarbeit mit Displate helfen wir LEC-Fans dabei, ihre Battlestations aufzurüsten.

WARSCHAU, Polen, June 15, 2023 (GLOBE NEWSWIRE) -- Da der LEC Summer Split 2023 vor der Tür steht, ist es

Highly Anticipated Chancer Crypto Presale Officially Launches Today: https://www.valuewalk.com/wp-content/uploads/2023/06/gold-challenge-comp_1372_1686580560dLoepWAWIW-300x180.jpg
Highly Anticipated Chancer Crypto Presale Officially Launches Today

London, United Kingdom, June 13th, 2023, Chainwire

Chancer, one of the most exciting new Web3 projects of 2023 has officially launched its crypto presale today, 13th June. The project aims to

Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business: https://www.valuewalk.com/wp-content/uploads/2023/02/Home-Depot-Stock-300x150.jpeg
Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business

A second missive claiming ‘blemished’ channel misdoings are having little impact on Hong Kong-traded shares

Short-seller Jehoshaphat Research (JR) has accused Techtronic Industries (HKG:0669) of

Shareholders Denounce Merck’s Lawsuit Against HHS: https://www.valuewalk.com/wp-content/uploads/2023/06/Merck-Co-300x150.jpeg
Shareholders Denounce Merck’s Lawsuit Against HHS

Shareholders denounce Merck’s lawsuit against HHS as a transparent campaign to protect profits at the expense of patients

Shareholders Deem Merck’s Lawsuit Against HHS As Unconstitutional

NEW